Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer
Escudero, D.; Barnadas, A.; Codina, M.; Fueyo, J.; Graus, F.
Neurology 43(8): 1605-1606
1993
ISSN/ISBN: 0028-3878 PMID: 8351021 Document Number: 405849
A 59-year-old woman with breast cancer and anti-Ri antibodies developed a neurologic paraneoplastic disorder characterized by nausea, vomiting, vertigo, paresis of upward gaze, and gait ataxia, without opsoclonus. The absence of opsoclonus does not rule out the possibility of an anti-Ri-associated paraneoplastic neurologic disorder.
Document emailed within 1 workday
Related Documents
Morita, H.; Hirota, T.; Mune, T.; Suwa, T.; Ishizuka, T.; Inuzuka, T.; Tanaka, K.; Ishimori, M.; Nakamura, S.; Yasuda, K. 2005: Paraneoplastic neurologic syndrome and autoimmune Addison disease in a patient with thymoma American Journal of the Medical Sciences 329(1): 48-51Murgić, J.; Prpić, M.; Kirac, I.; Camino-Varela, A.-M.; Bolanca, A.; Kusić, Z. 2012: Dermatomyositis as paraneoplastic syndrome of peritoneal and ovarian relapse after long-term complete remission in patient with metastatic bilateral breast cancer Collegium Antropologicum 36(1): 325-329
Schadlow, M.B.; Anhalt, G.J.; Sinha, A.A. 2003: Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus Journal of Drugs in Dermatology: Jdd 2(5): 564-567
Wichowicz, H. 2003: A manic episode as a result of information about breast cancer diagnosis in a patient suffering from bipolar affective disorder Psychiatria Polska 37(5): 845-850
Takeda, Y.; Tanaka, N.; Konishi, J. 2012: Combination of trastuzumab, aromatase inhibitor and anti-cancer drugs obtained a good prognosis for an inoperable stage IIi B breast cancer patient with giant skin ulceration Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(4): 629-632
Koroleva, E.S.; Losenkov, I.S.; Alifirova, V.M.; Ivanova, S.A.; Goldberg, V.E.; Novikova, N.S. 2014: Diagnosis of paraneoplastic polyneuropathy in patients with breast cancer and small cell lung cancer Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(4): 93-96
de Toffol, B.; Uchuya, M.; Michalak, S.; Corcia, P.; Hommet, C.; Autret, A. 1997: Paraneoplastic encephalomyeloneuritis with anti-Hu antibodies and cancer of the rectum Revue Neurologique (Paris) 153(2): 135-137
Valverde-Garcia, J.; Juanola-Roura, X.; Ruiz-Martin, J.M.; Nolla-Sole, J.M.; Rodriguez-Moreno, J.; Roig-Escofet, D. 1987: Paraneoplastic palmar fasciitis-polyarthritis syndrome associated with breast cancer Journal of Rheumatology 14(6): 1207-1209
Caceres, G.; Dauphinee, M.J.; Eisele, L.E.; MacColl, R.; Mizejewski, G.J. 2002: Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein Anticancer Research 22(5): 2817-2820
Vickers, S.M.; Niederhuber, J.E. 1997: Hodgkin's disease associated with neurologic paraneoplastic syndrome Southern Medical Journal 90(8): 839-844
Pelikán, F.; Timová, S. 1997: Autoimmune mechanisms in the pathogenesis of neurologic paraneoplastic diseases Bratislavske Lekarske Listy 98(6): 335-338
Katagiri, T.; Horikawa, Y.; Hayashi, M.; Tsubaki, T. 1981: Opsoclonus and ocular myoclonus. Two abnormal spontaneous eye movements occurring in the same patient--two case report Rinsho Shinkeigaku 21(1): 42-46
Bartoloni, E.; Alunno, A.; Gerli, R. 2012: Primary Sjögren's syndrome as paraneoplastic disorder: a case report Clinical and Experimental Rheumatology 30(3): 454
Tominaga, T. 1999: Recent development of oral anti-cancer drugs for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(3): 301-307
Hosotani, Y.; Morimatsu, T.; Takata, M.; Mimura, O. 2016: A Case of a Corneal Disorder after Breast Cancer Treatment with Nab-paclitaxel Nippon Ganka Gakkai Zasshi 120(6): 449-453
Durai, R.; Ruhomauly, S.N.; Wilson, E.; Hoque, H. 2009: Metastatic renal cell carcinoma presenting as a breast lump in a treated breast cancer patient Singapore Medical Journal 50(8): e277-e279
Cheng, Y.H.; Jenardhanan, P.; Mathur, P.P.; Qian, X.; Xia, W.; Silvestrini, B.; Cheng, C.Y. 2014: Interaction of oligomeric breast cancer resistant protein (BCRP) with adjudin: a male contraceptive with anti-cancer activity Current Molecular Pharmacology 7(2): 147-153
Monden, K.; Sakurai, K.; Fujisaki, S.; Kubota, H.; Suzuki, Y.; Adachi, K.; Suzuki, S.; Tomita, R. 2019: The Diagnostic Problem of Automated Breast Volume Scanner(ABUS)for a Breast Cancer Patient with Dementia-A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(2): 345-347
Zhang, X.Q.; Yang, C.Y.; Rao, X.F.; Xiong, J.P. 2016: Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators European Journal of Gynaecological Oncology 37(1): 30-35
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539